C-section recovery extends the timeline
Beyond semaglutide, other innovative GLP-1 receptor agonist medications, such as Tirzepatide , which is also a GIP receptor agonist, are available and FDA-approved for once-weekly administration under brand names like Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management)
Mounjaro Injection Site Reaction: Rash, Itching & Relief Local skin reaction to Mounjaro (tirzepatide) is a common occurrence following subcutaneous injection of this dual GIP/GLP-1 receptor agonist used for type 2 diabetes mellitus
Apart from semaglutide drugs, other antidiabetic medications studied were insulin, metformin, dipeptidyl-peptidase-4 inhibitors, sodium-glucose cotransporter-2 inhibitors, sulfonylureas, thiazolidinediones, and other GLP-1RAs